Jascayd Approved in China for The Treatment of IPF
22 Oct 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim Picks Orsini as Jascayd Specialty Pharmacy
14 Oct 2025 //
PR NEWSWIRE
Boehringer Breaks IPF Treatment Drought with New FDA approval
09 Oct 2025 //
FIERCE PHARMA
Boehringer Ingelheim’s Jascayd Receives Approval In US
07 Oct 2025 //
FDA
ERS Data: Nerandomilast Lowers Death Risk in IPF, PPF
30 Sep 2025 //
PHARMAWEB
Boehringer`s phase 3 lung data get muted response from analysts
20 May 2025 //
FIERCE BIOTECH
Boehringer widens fibrosis drug`s potential after 2nd ph. 3 win
11 Feb 2025 //
PRESS RELEASE

Market Place
Sourcing Support